149 related articles for article (PubMed ID: 36511111)
1. Postpartum medical management of hypertension and risk of readmission for hypertensive complications.
Lovgren T; Connealy B; Yao R; D Dahlke J
J Hypertens; 2023 Feb; 41(2):351-355. PubMed ID: 36511111
[TBL] [Abstract][Full Text] [Related]
2. Postpartum Readmission for Hypertension After Discharge on Labetalol or Nifedipine.
Do SC; Leonard SA; Kan P; Panelli DM; Girsen AI; Lyell DJ; El-Sayed YY; Druzin ML; Herrero T
Obstet Gynecol; 2022 Oct; 140(4):591-598. PubMed ID: 36075068
[TBL] [Abstract][Full Text] [Related]
3. Postpartum management of hypertension and effect on readmission rates.
Lovgren T; Connealy B; Yao R; Dahlke JD
Am J Obstet Gynecol MFM; 2022 Jan; 4(1):100517. PubMed ID: 34757235
[TBL] [Abstract][Full Text] [Related]
4. Risk of postpartum readmission after hypertensive disorder of pregnancy and variation by discharge antihypertensive medication prescription.
Mitro SD; Hedderson M; Xu F; Forquer H; Baker JM; Kuzniewicz MW; Greenberg M
Am J Obstet Gynecol; 2024 Jan; ():. PubMed ID: 38280432
[TBL] [Abstract][Full Text] [Related]
5. Oral labetalol compared to oral nifedipine for postpartum hypertension: A randomized controlled trial.
Sharma KJ; Greene N; Kilpatrick SJ
Hypertens Pregnancy; 2017 Feb; 36(1):44-47. PubMed ID: 27786578
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of extended postpartum inpatient monitoring for hypertensive disorders of pregnancy to reduce the risk of readmission for preeclampsia with severe features.
Bronner BA; Trowbridge PL; Perry AC; McCormick AC; Waters TP; de Los Reyes S
Am J Obstet Gynecol MFM; 2023 Jul; 5(7):100956. PubMed ID: 37023986
[TBL] [Abstract][Full Text] [Related]
7. The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy.
Shawkat E; Mistry H; Chmiel C; Webster L; Chappell L; Johnstone ED; Myers JE
Pregnancy Hypertens; 2018 Jan; 11():92-98. PubMed ID: 29523282
[TBL] [Abstract][Full Text] [Related]
8. Pulse pressure as a predictor of response to treatment for severe hypertension in pregnancy.
Mullan SJ; Vricella LK; Edwards AM; Powel JE; Ong SK; Li X; Tomlinson TM
Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100455. PubMed ID: 34375751
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
Vermillion ST; Scardo JA; Newman RB; Chauhan SP
Am J Obstet Gynecol; 1999 Oct; 181(4):858-61. PubMed ID: 10521742
[TBL] [Abstract][Full Text] [Related]
10. Race/ethnicity differences in response to acute antihypertensive treatment of peripartum severe hypertension.
Greene NH; Pon FF; Kilpatrick SJ
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10103-10109. PubMed ID: 36042568
[TBL] [Abstract][Full Text] [Related]
11. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.
Ohman KP; Weiner L; von Schenck H; Karlberg BE
Eur J Clin Pharmacol; 1985; 29(2):149-54. PubMed ID: 3908121
[TBL] [Abstract][Full Text] [Related]
13. Postpartum Hypertension: Etiology, Diagnosis, and Management.
Sharma KJ; Kilpatrick SJ
Obstet Gynecol Surv; 2017 Apr; 72(4):248-252. PubMed ID: 28426127
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with early readmission for postpartum hypertension.
Pressman K; Wellcome J; Pooran C; Crousillat D; Cain MA; Louis JM
AJOG Glob Rep; 2024 May; 4(2):100323. PubMed ID: 38919706
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.
Ueng KC; Ningling S; El Maksod A; Hung KY; Yuehui Y
Clin Drug Investig; 2011; 31(9):631-42. PubMed ID: 21591818
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial comparing the efficacy of nifedipine and enalapril in the postpartum period.
Yoselevsky EM; Seely EW; Celi AC; Robinson JN; McElrath TF
Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101178. PubMed ID: 37806651
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with postpartum readmission for hypertensive disorders of pregnancy.
Bruce KH; Anderson M; Stark JD
Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100397. PubMed ID: 33991709
[TBL] [Abstract][Full Text] [Related]
18. Oral labetalol versus oral nifedipine in hypertensive urgencies in the ED.
McDonald AJ; Yealy DM; Jacobson S
Am J Emerg Med; 1993 Sep; 11(5):460-3. PubMed ID: 8363681
[TBL] [Abstract][Full Text] [Related]
19. Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
Kantorowska A; Heiselman CJ; Halpern TA; Akerman MB; Elsayad A; Muscat JC; Sicuranza GB; Vintzileos AM; Heo HJ
Am J Obstet Gynecol; 2020 Aug; 223(2):250.e1-250.e11. PubMed ID: 32067968
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure medication use and postpartum hospital readmission among preeclampsia patients.
Gesner T; Fogel J; Bryson L
Hypertens Pregnancy; 2023 Dec; 42(1):2226210. PubMed ID: 37358058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
